ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$SLN:NASDAQ · SILENCE THERAPEUTICS PLC

Silence Therapeutics — siRNA drugs

Sector: health

Conviction from: NASDAQCitrini

52-week range: 4.1919.86

3 tracked filer(s) hold this · 3 opened, 0 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 56 — mean of 3 scored holder(s) · buyers (new/add) avg 56. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy44,252$483,6740.0%
Steve Cohen / Point7275New buy40,192$439,2990.0%
George Soros / Soros Fund Mgmt33New buy100,000$1,093,0000.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.